Position in ADCT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$13,483
New position
Shares Held
12,601
first reported quarter
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 113 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Pallas Capital Advisors LLC holds $4,121,079 across 10 Drug Manufacturers - Specialty & Generic names. ADCT ranks #10 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
9,265 | $1,561,523 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,227 | $1,206,655 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
7,667 | $490,304 | |
| 4 | IRWD |
Ironwood Pharmaceuticals Inc
|
73,996 | $311,523 | |
| 5 | ZTS |
Zoetis Inc.
|
4,142 | $297,644 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
10,059 | $100,590 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
11,152 | $88,323 | |
| 8 | ORGO |
Organogenesis Holdings Inc.
|
15,150 | $36,814 |
All Filings in ADCT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,483 | 12,601 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||